nature.com
Safety and pharmacokinetics of the non-hormonal male contraceptive YCT-529 - Communications Medicine
Mannowetz et al. evaluate the safety and tolerability of the small molecule YCT-529 and show that single doses of up to 180 mg were well tolerated in healthy male subjects of this Phase 1a clinical tr...